A product of independent beta probabilities dose escalation design for dual‐agent phase I trials (Q153908)

From MaRDI portal
Revision as of 11:44, 9 December 2024 by Import241208061232 (talk | contribs) (Normalize DOI.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
A product of independent beta probabilities dose escalation design for dual‐agent phase I trials
scientific article

    Statements

    34
    0 references
    8
    0 references
    1261-1276
    0 references
    29 January 2015
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references